Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure
- PMID: 24464745
- PMCID: PMC4238830
- DOI: 10.1002/ejhf.48
Implantable device diagnostics on day of discharge identify heart failure patients at increased risk for early readmission for heart failure
Abstract
Aims: We hypothesized that diagnostic data in implantable devices evaluated on the day of discharge from a heart failure hospitalization (HFH) can identify patients at risk for HF readmission (HFR) within 30 days.
Methods and results: In this retrospective analysis of four studies enrolling patients with CRT devices, we identified patients with a HFH, device data on the day of discharge, and 30-day post-discharge clinical follow-up. Four diagnostic criteria were evaluated on the discharge day: (i) intrathoracic impedance>8 Ω below reference impedance; (ii) AF burden>6 h; (iii) CRT pacing<90%; and (iv) night heart rate>80 b.p.m. Patients were considered to have higher risk for HFR if ≥2 criteria were met, average risk if 1 criterion was met, and lower risk if no criteria were met. A Cox proportional hazards model was used to compare the groups. The data cohort consisted of a total of 265 HFHs in 175 patients, of which 36 (14%) were followed by HFR. On the discharge day, ≥2 criteria were met in 43 (16% of 265 HFHs), only 1 criterion was met in 92 (35%), and none of the four criteria were met in 130 HFHs (49%); HFR rates were 28, 16, and 7%, respectively. HFH with ≥2 criteria met was five times more likely to have HFR compared with HFH with no criteria met (adjusted hazard ratio 5.0; 95% confidence interval 1.9–13.5, P=0.001).
Conclusion: Device-derived diagnostic criteria evaluated on the day of discharge identified patients at significantly higher risk of HFR.
© 2013 The Authors. European Journal of Heart Failure
Figures



Similar articles
-
Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.Am J Cardiol. 2013 Jan 1;111(1):79-84. doi: 10.1016/j.amjcard.2012.08.050. Epub 2012 Oct 2. Am J Cardiol. 2013. PMID: 23040596
-
Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds.Heart Lung. 2015 Mar-Apr;44(2):129-36. doi: 10.1016/j.hrtlng.2014.07.007. Epub 2014 Dec 24. Heart Lung. 2015. PMID: 25543319 Free PMC article.
-
Prediction of heart failure hospitalizations based on the direct measurement of intrathoracic impedance.ESC Heart Fail. 2020 Oct;7(5):3040-3048. doi: 10.1002/ehf2.12930. Epub 2020 Aug 13. ESC Heart Fail. 2020. PMID: 32790059 Free PMC article.
-
Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10. doi: 10.1016/j.jacc.2009.11.089. J Am Coll Cardiol. 2010. PMID: 20413029
-
Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.Int J Cardiol. 2016 Oct 1;220:855-61. doi: 10.1016/j.ijcard.2016.06.080. Epub 2016 Jun 23. Int J Cardiol. 2016. PMID: 27400184
Cited by
-
Device-detected congestion is associated with worse patient-reported outcomes in heart failure.Heart Lung. 2019 May-Jun;48(3):208-214. doi: 10.1016/j.hrtlng.2018.12.003. Epub 2019 Jan 2. Heart Lung. 2019. PMID: 30611529 Free PMC article.
-
Redefining the role of biomarkers in heart failure trials: expert consensus document.Heart Fail Rev. 2017 May;22(3):263-277. doi: 10.1007/s10741-017-9608-5. Heart Fail Rev. 2017. PMID: 28332132 Review.
-
Risk Prediction in Transition: MAGGIC Score Performance at Discharge and Incremental Utility of Natriuretic Peptides.J Card Fail. 2020 Jan;26(1):52-60. doi: 10.1016/j.cardfail.2019.11.016. Epub 2019 Nov 18. J Card Fail. 2020. PMID: 31751788 Free PMC article.
References
-
- McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–869. - PubMed
-
- Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–1428. - PubMed
-
- McDonagh TA, Blue L, Clark AL, Dahlstrom U, Ekman I, Lainscak M, McDonald K, Ryder M, Stromberg A, Jaarsma T. European Society of Cardiology Heart Failure Association Standards for delivering heart failure care. Eur J Heart Fail. 2011;13:235–241. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous